Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › TX › Grand Prairie › NPI 1417134255
Physician

Epifania M. Caturay, Mdpa

Epifania M. Caturay, Mdpa was paid $4.22M by Medicaid between Jan 2018 and Dec 2024, across 77 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 28% of everything it billed.

33Billing provider infoEPIFANIA M. CATURAY, MDPA
GRAND PRAIRIE, TX 75051
33aNPI1417134255assigned 01/23/2008
33bProvider typePediatrics Physician
28Total paid$4.22M
24GClaims243,623
24DCodes billed77
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other Pediatrics Physician providers in Texas

Rank by total paid#106 of 1,136
Median peer was paid$329K
This provider vs. median13×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$50K$100K$150K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
20181,296$41K
20191,024$36K
202020,683$353K
202176,488$1.33M
202266,994$1.00M
202352,652$903K
2024incomplete24,486$553K
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99213 Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity 28% 37,785 33,369 $1.16M
99392 Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) 12% 8,056 7,291 $519K
99391 Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) 11% 7,340 6,501 $450K
99393 Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) 9.3% 5,928 5,229 $391K
99394 Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) 7.0% 4,197 3,751 $297K
90460 Immunization administration through 18 years of age via any route, first or only component 7.0% 34,387 15,106 $294K
S8301 Infection control supplies, not otherwise specified 6.0% 9,428 8,009 $255K
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward 2.4% 5,212 4,722 $101K
90472 Immunization administration, each additional vaccine (list separately) 2.3% 9,244 2,393 $96K
99214 Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 1.5% 1,699 1,522 $65K
87426 Infectious agent antigen detection, SARS-CoV-2 (COVID-19) 1.3% 1,686 1,170 $54K
99381 1.3% 880 798 $54K
65 more codes
96110 Developmental screening, with scoring and documentation, per standardized instrument 1.1% 7,581 $47K
99203 Doctor's office visit, new patient (routine) 1.0% 995 $43K
90461 1.0% 8,170 $43K
97802 <1% 11,736 $39K
99460 <1% 584 $35K
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine <1% 2,843 $32K
99238 Hospital discharge day management, 30 minutes or less <1% 727 $28K
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets <1% 425 $22K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe <1% 478 $21K
99001 <1% 4,226 $18K
99383 <1% 300 $18K
99442 <1% 500 $18K
99384 <1% 202 $16K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type <1% 1,744 $13K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A <1% 1,441 $13K
92551 <1% 5,618 $13K
99382 <1% 167 $7K
83655 <1% 1,403 $7K
99050 <1% 520 $7K
96160 <1% 8,025 $6K
99422 <1% 617 $5K
94760 <1% 3,608 $4K
T1013 Sign language or oral interpretive services, per 15 minutes <1% 111 $4K
0001A <1% 122 $3K
99462 <1% 82 $2K
99395 Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years <1% 31 $2K
0071A <1% 50 $2K
94761 <1% 927 $2K
0002A <1% 115 $2K
90677 <1% 773 $2K
86769 <1% 64 $1K
85018 <1% 1,437 $1K
86328 <1% 19 $859.37
96161 <1% 4,605 $703.26
36415 Collection of venous blood by venipuncture <1% 493 $593.32
99202 Office or other outpatient visit for the evaluation and management of a new patient, straightforward <1% 14 $467.49
87807 <1% 66 $436.41
99441 <1% 18 $416.24
81002 <1% 98 $269.64
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe <1% 17 $176.88
87400 <1% 28 $154.31
81003 <1% 48 $75.60
90734 <1% 1,293 $27.89
90670 <1% 4,753 $27.72
A9150 Non-prescription drugs <1% 211 $24.62
36416 <1% 468 $24.30
90648 <1% 5,512 $24.11
99173 <1% 7,798 $14.44
90686 <1% 5,969 $1.53
90723 <1% 6,558 $0.90
90620 <1% 891 $0.49
90651 <1% 1,492 $0.23
91307 <1% 138 $0.20
90715 <1% 666 $0.14
90710 <1% 3,288 $0.11
90681 <1% 1,889 $0.11
90633 <1% 2,508 $0.05
90688 <1% 627 $0.04
91300 <1% 352 $0.03
90696 <1% 962 $0.03
90700 <1% 961 $0.01
G9920 Screening performed and negative 0% 212 $0.00
G9919 Screening performed and positive and provision of recommendations 0% 165 $0.00
99080 0% 15 $0.00
99051 0% 25 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialCATURAY, EPIFANIA (PRESIDENT)